openPR Logo
Press release

Antiviral Drug Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031

05-15-2024 01:16 PM CET | Health & Medicine

Press release from: Orion Market Research

Antiviral Drug Market Size, Trends, Latest Insights, Analysis

The global antiviral drugs market is estimated to witness significant growth during the forecast period. Increasing viral infections such as Human immune deficiency virus (HIV), influenza A & B, hepatitis B & C are the major driving factor of the global antiviral drug market. There have been considerable advances in the innovation as well as the demand for HIV drugs. According to UN India, Pakistan and China are among the top 10 nations, that account for 95% of the total HIV infection cases in 2017. According to Avert, in 2017, an estimated 2.1 million people of India are living with HIV, 88,000 people got infected by HIV in this year and 69,000 AIDS-related deaths happened. Hence, growing number of HIV positive cases are creating hugh demand for antiviral drugs.

To learn more about this report request a sample copy @

Growing investment for research and development and drug development is expected to drive the global antiviral drugs market. For instance, in December 2019, NIH and Bill & Melinda Gates Foundation collaborated on Gene-based HIV cure treatment, they invested a total of $200 million. In October 2019, the US Food and Drug Administration (FDA) approved tenofovir Elafenamide 25 mg and Emtricitabine 200 mg to reduce the risk of HIV infection through sex. In April 2019, Dolutegravir and Lamivudine got approval from the US FDA, it can be used for a regimen for treatment-naïve adults with HIV-1. Moreover, in March 2020, for the second time, a patient cured of HIV infection.

Hepatitis is a viral infection, it damages the liver. According to Avert, each year, around 1.75 million new people got affected by Hepatitis C. According to WHO, in 2015, an estimated 1% of the world population are living with Hepatitis C. Among them, 20% were aware of it and 7.4% among was diagnosed, and in 2016 this increased to 13%. In August 2017, the US FDA approved Mavyret (glecaprevir/pibrentasvir), it can be used for the treatment of six genotypes of Hepatitis-C. In July 2017, the US FDA approved Vosevi (sofosbuvir/velparasvir/voxilapre), it can be used for treatment for any genotype of hepatitis C. It is intended for those people who were previously treated with sofosbuvir but hadn't get viral clearance.

Among these viral infections, Influenza is an acute viral infection. According to the World Health Organization (WHO), in the northern fraction, approximately 5-15% of the population has been affecting by Influenza flu annually, and Clinical Infection Diseases (CID, Oxford Academic) found that the attack rate of Influenza, a median 9.3% are for the age group 0-17 years, 8.8% for 18-64 years, and 3.9% for 65 years and older. According to the Center for Disease Control and Prevention, the Us, from October 2019 to March 2020 there has been 36,000,000-51,000,000 Influenza flu illness happened, among them, 17,000,000-24,000,000 visited medical centers, 370,000-670,000 were hospitalized and 22,000-55,000 death case happened. In October 2018, Harvard Medical School developed a drug for Influenza flu, Baloxavir (Xofluza) and got approval from the US FDA. It can be used for treatment for both influenza A & B.

Global Antiviral Drugs Market Segmentation

By Application

• Influenza (Flu) Antiviral Drugs
• Hepatitis Antiviral Drugs
• HIV Antiviral Drugs
• Herpes Antiviral Drugs
• Others

By Types

• Branded
• Generic

A full report of Global Antiviral Drug Market is available at:

Global Antiviral Drug Market- Segment by Region

North America

• United States
• Canada


• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe


• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AbbVie, Inc.
• Arbutus Biopharma Corp.
• Aurobindo Pharma, Ltd.
• BioCryst Pharmaceuticals, Inc.
• Bristol-Myers Squibb Co.
• Cipla, Inc.
• Reddy's Laboratories, Ltd.
• Hoffmann-La Roche AG
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

Media Contact:

Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drug Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031 here

News-ID: 3497607 • Views:

More Releases from Orion Market Research

Punnet Packaging Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | AVI Global Plast Pvt Ltd., Smurfit Kappa Group plc, INFIA srl, Berry Global, and Coveris Holdings SA
Punnet Packaging Market is Likely to Increase at a Significantly High CAGR durin …
Global punnet packaging market is anticipated to grow at a CAGR of 5.4% during the forecast period (2024-2031). The growing demand for high-barrier and tear-resistant packaging solutions among end-users to maximize the shelf life of perishable goods is driving the demand for punnet packaging. Personalized punnets with a retailer's logo, color palette, or unique design can help them stand out from the competition and improve brand recognition. Retail establishments may stand out
Milk Packaging Market Update Report 2024| Industry Trends, Demand, Leading Companies and Segmentation till 2031/ Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
Milk Packaging Market Update Report 2024| Industry Trends, Demand, Leading Compa …
Milk packaging market is projected to grow at a CAGR of over 4% during the forecast period. Milk is one of the highest consumed dairy products across the globe and is the most complex in storing for a long period of time owing to its moisture and other mineral contents. Packaging methods of the dairy industry are progressively changing in order to meet the requirements of consumers and the rest
Liquid Packaging Cartons Market Worldwide Industry Analysis, Future Demand and Forecast till 2031
Liquid Packaging Cartons Market Worldwide Industry Analysis, Future Demand and F …
The global liquid packaging cartons market is estimated to grow at a CAGR of 5.0% during the forecast period. Carton packaging is one of the most sustainable packaging solutions, which uses the paper board produced from renewable wood. Its space-saving and lightweight design facilitate filling and transportation of food and beverages. These packs are easy to open, eye-catching, and outfitted with all essential convenience factor. Carton packaging for beverages has
Instant Beverage Premix Market: Trends and Opportunities/ Pepsico, Inc., Nestlé S.A., The Coca-Cola Co., Dunkin Group, Inc.
Instant Beverage Premix Market: Trends and Opportunities/ Pepsico, Inc., Nestlé …
The global instant beverage premix market is anticipated to grow at a CAGR of 6.3% during the forecast period. Rising launches of instant beverage premixes with organic and natural ingredients and with functional claims are found to be very appealing to consumers who crave a variety of drinks. Growing health consciousness among consumers is inclining them towards ingredients such as turmeric, ginger, cardamom, lemon, black pepper, clove, mint, cinnamon, and apple cider

All 5 Releases

More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral